| Literature DB >> 29273692 |
Benjamin Stahl1,2,3,4, Bettina Mohr5, Verena Büscher6, Felix R Dreyer6, Guglielmo Lucchese2,6, Friedemann Pulvermüller6,7.
Abstract
OBJECTIVE: Recent evidence has fuelled the debate on the role of massed practice in the rehabilitation of chronic post-stroke aphasia. Here, we further determined the optimal daily dosage and total duration of intensive speech-language therapy.Entities:
Mesh:
Year: 2017 PMID: 29273692 PMCID: PMC6031278 DOI: 10.1136/jnnp-2017-315962
Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN: 0022-3050 Impact factor: 10.154
Figure 1Consolidated Standards of Reporting Trials flow diagram.
Intensive regimens
| Group I | Group II | |
| Intervention type | ILAT | ILAT |
| Daily practice | 4 hours | 2 hours |
| Weekly practice | 12 hours | 6 hours |
| Therapy frequency | 3 weekly sessions | 3 weekly sessions |
| Duration of each trial phase | 6 consecutive working days | 6 consecutive working days |
| Total amount of practice | 48 hours | 24 hours |
| Total treatment duration | 4 weeks | 4 weeks |
Thirty patients with chronic post-stroke aphasia were randomly assigned to one of two treatment groups: patients receiving ILAT with 4 hours (Group I) or with 2 hours of daily practice (Group II).
ILAT: Intensive Language-Action Therapy.
Figure 2Lesion overlay maps. Patients received Intensive Language-Action Therapy with 4 hours (Group I; see panel A) or with 2 hours of daily practice (Group II; see panel B). Different colours indicate the degree of lesion overlap in each treatment group.
Figure 3Aphasia test results. Changes in language performance on the Aachen Aphasia Test (AAT; see panel A) and on the Action Communication Test (ACT; see panel B). Thirty individuals with chronic post-stroke aphasia were randomly assigned to one of the two Groups: patients receiving Intensive Language-Action Therapy with 4 hours (Group I) or with 2 hours of daily practice (Group II). All patients went through an initial waiting period (‘baseline’) and two successive training intervals (‘therapy phase’). Each trial phase lasted 2 weeks. Testing took place at four points in Time: 2 weeks before treatment onset (T0), at treatment onset (T1), after the first training interval (T2) and after the second training interval (T3). Focusing on changes in language performance separately for each trial phase [Δ(T1–T0); Δ(T2–T1); Δ(T3–T2)], statistics refer to significant paired-sample t-tests (asterisks embedded in bar graphs) and to a significant Time-by-Group interaction, as revealed by repeated-measures analyses of variance (asterisks displayed above bar graphs; *P<0.05, **P<0.01). Error bars represent CIs corrected for between-subject variance.22 Independent-sample t-tests confirmed that Group I and Group II did not differ significantly with regard to their performances on the AAT (P=0.62) or on the ACT (P=0.62) at baseline (T0).
Aphasia test results
| T0 | T1 | T2 | T3 | Δ(T1–T0) | Δ(T2–T1) | Δ(T3–T2) | Δ(T3–T1) | |
| Mean AAT scores | ||||||||
| Group I | 49.7 | 50.3 | 51.9 | 52.7 | 0.6 | 1.6*** | 0.8 | 2.4** |
| Group II | 51.2 | 51.2 | 53.0 | 53.4 | 0.0 | 1.8*** | 0.4 | 2.2*** |
| Both groups | 50.5 | 50.7 | 52.5 | 53.1 | 0.3 | 1.7*** | 0.6* | 2.3*** |
| Mean ACT scores | ||||||||
| Group I | 49.1 | 49.2 | 50.6 | 50.2 | 0.1 | 1.4** | −0.4 | 1.0 |
| Group II | 50.9 | 51.1 | 53.4 | 54.0 | 0.2 | 2.3*** | 0.6* | 2.9*** |
| Both groups | 50.0 | 50.2 | 52.0 | 52.1 | 0.2 | 1.8*** | 0.1 | 1.9*** |
Mean t-scores obtained on the Aachen Aphasia Test (AAT)9 and on the Action Communication Test (ACT).16 Thirty individuals with chronic post-stroke aphasia were randomly assigned to one of two treatment groups: patients receiving Intensive Language-Action Therapy with 4 hours (Group I) or with 2 hours of daily practice (Group II). Both treatment groups went through an initial waiting period and two successive training intervals. Each phase lasted 2 weeks. Patients were tested at four points in time: 2 weeks before treatment onset (T0), at treatment onset (T1), after the first training interval (T2) and after the second training interval (T3). Asterisks refer to significant paired-sample t-tests (*P<0.05, **P<0.01, ***P<0.001) assessing changes in language performance separately for each time interval [Δ(T1–T0); Δ(T2–T1); Δ(T3–T2)] and across the entire therapy phase [Δ(T3–T1)].